4/14/2021SAMR Fines Yangtze River Pharma CNY 764M for Violations of Anti-Monop...

4/13/2021Abcam and MEDx Extend Precision Medicine Strategic Partnership

4/13/2021Pharma MNCs Step Up Alliances with Local Players in Chinese Market

4/13/2021China Approves New COVID-19 Vaccine for Clinical Trials

4/13/2021NMPA Revises Package Inserts of Tramadol Hydrochloride Suppository and...

4/12/2021NMPA Accepts NDA for Ocumension's OT-401 (YUTIQ) on Real World Data

4/12/2021Sorrento Therapeutics To Buy ACEA Therapeutics For $38M in Stock

4/12/2021PharmaDJ's China Biotech Fundraising Tracker: Feb 2021

4/12/2021FiercePharma: BeiGene Details Novartis-partnered PD-1's First Global P...

4/9/2021Recent Executive Moves

4/8/2021China to Improve BMI Outpatient Coverage As It Reforms Individual Acco...

4/8/2021China Introduces New Preferential Policies in Hainan to Boost Sectors ...

4/8/2021Biogen and Bio-Thera Solutions Announce License Deal for Actemra Biosi...

4/8/2021BeiGene's Guangzhou Biologics Plant Granted First Commercial Manufactu...

4/8/2021China's 14th Five-Year Plan (2021-2025): Signposts for Doing Business ...

4/7/2021Chime Bio Builds Second Biomanufacturing Facility in Wuhan After Rais...

4/6/2021Crystec Launches New R&D Center in China

4/6/2021iX Biopharma Enters Cooperation Deal with China Resources Pharma Comme...

4/5/2021SMEI: Performance Review of Drug Products Included in the NRDL through...

4/2/2021Recent Executive Moves

4/1/2021NHC Solicits Comments on Draft Long Term Drug Prescription Management ...

4/1/2021Patent Term Extension and Patent Linkage for Pharmaceutical Patents in...

3/31/2021China's Healthcare System: Addressing Capacity Shortfalls before and a...

3/31/2021Everest Medicines Granted Clinical Trial Approval to Evaluate Trodelv...

3/31/2021Albumedix Enters Recombinant Human Albumin Supply Partnership with FU...

3/31/2021Eucure Bio Announces Breakthru Phase I Results for Anti-CTLA-4 Therapy...

3/31/2021CDE Solicits Comments on Three Technical Guidelines for Nanomedicines

3/31/2021Financial-related Company News in Brief

3/30/2021China Plans "Unprecedented" Investment into TCM with Doubling Budget i...

3/30/2021Henlius and NeuPharma Enter License Deal for BRAF V600E Inhibitor

Page:97/361 Total number of articles:10820: [First][<<] [95] [96] [97] [98] [99] [>>] [End]